Table 2.
Field | Agenda | Reference |
---|---|---|
Angiogenesis of RA synovium | Roles of MC origin mediators (such as tryptase, chymase, histamine) on neo-angiogensis of RA synovium | [47,48] |
Chemoattractive role in RA synovium | Ability to recruit various immune cells, neutrophil, NK cell, T cell, monocytes via secreting chemokines (TNF-α, CCL2, CCL5, IL-8, LTB4) | [86] |
APC function | Activation of other immune cells, such as T cells, via antigen presenting function of MC | [64,65,66,87] |
Osteoclastogenesis | Osteoclastogenesis via histamine secreted by MCs | [39,40] |
Pharmacologic intervention | c-kit tyrosine kinase inhibitor (imatinib) treatment induced apoptosis of MCs and reduced TNF-α production in RA synovium | [60] |
Anti-allergic medication, tranilast, suppressed TNF-α production in MC of RA mice model | [61] | |
MC suppression by salbutamol and cromolyn reduced joint destruction and angiogenesis in RA mice model | [79] |
MC, mast cell; RA, rheumatoid arthritis; NK, natural killer; TNF-α, tumor necrosis factor-α; CCL, CC chemokine ligand; IL, interleukin; LTB4, leukotriene B4; APC, antigen presenting cell.